$10.13
0.484.97%
At close: -
$9.94
-0.19-1.86%
After Hours: Nov 22, 4:54 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Avalo Therapeutics in recent months.
Browse guidance and forecast on all stocks.